AlphaMaven AlphaMaven

PE-Backed Chemicals Maker GChem To Be Sold In $850M Deal

Reported by Law360
Aug 5, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • ContextLogic Holdings Inc. and affiliates will acquire chemicals maker gChem from private equity firm EagleTree Capital and co-investors for $850 million enterprise value, as announced August 5, 2026.
  • • The transaction represents an exit for EagleTree Capital and its co-investment partners from their stake in the PE-backed chemicals manufacturer.
  • • ContextLogic's acquisition of gChem expands its footprint in the specialty chemicals sector through a significant add-on or platform investment.
Summary
ContextLogic Holdings Inc. and its affiliates have agreed to purchase gChem, a private equity-backed chemicals manufacturer, from EagleTree Capital and co-investors at an $850 million enterprise value. The transaction, announced on August 5, 2026, marks an exit event for the existing PE ownership group and represents a strategic acquisition for the buyer.

EagleTree Capital led the investment into gChem as a PE sponsor, with co-investors participating alongside the firm. The sale of the portfolio company at the announced enterprise value reflects the value creation achieved during the investment period under EagleTree's ownership.

ContextLogic's acquisition signals continued consolidation activity in the specialty chemicals sector, with established platform companies or investors pursuing add-on acquisitions to expand market position and operational scale. The $850 million valuation reflects current market conditions and the strategic positioning of gChem within the broader chemicals landscape.

The transaction is expected to close subject to customary closing conditions. Both parties announced the deal simultaneously, indicating a negotiated transaction structure between the buyer and seller.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Law360 PE-Backed Chemicals Maker GChem To Be Sold In $850M Deal